Analytical Description of X-Ray Peaks: Application to L X-Ray Spectra Processing of Lanthanide Elements by Means of the Electron Probe Micro-Analyzer

The shape of Lα X-ray peaks analyzed by means of a LiF (200 plane) monochromator was described by a pseudo-Voigt function: P(λ) = 0.35 P1(λ)+ 0.65 P2(λ) where P1(λ) and P2(λ) are a Gaussian and a Lorentzian distribution centered at the same wavelength, with the same amplitude and half-width and in relative proportion 0.35 and 0.65 respectively. For peaks occurring at wavelength greater than ≃ 0.17 nm, a Gaussian offset was added in order to correct the asymmetry of peaks resulting from the monochromator mounting within the spectrometer. The effective wavelength resolution was obtained by quadrature addition of the instrumental resolution and the natural width of the X-ray peaks. It has been shown that the difference in peak width of the L emission peaks of the lanthanide elements resulted from their difference in their natural widths. For these elements, the Lβ2, Lγ1 and Lγ2 were found to be accompanied by non-diagram lines, Lβ14, Lγ9 and Lγ10 respectively. The wavelength separation distances Lβ14-Lβ2, Lγ9-Lγ1 and Lγ10-Lγ2 were found consistent with the distances derived from the plasmon theory

Cathodoluminescence Applied to the Microcharacterization of Mineral Materials: A Present Status in Experimentation and Interpretation

Experimentation and interpretation of cathodoluminescence (CL) microscopy and spectroscopy applied to the microcharacterization of material minerals are reviewed. The origins of the intrinsic (host lattice) and extrinsic (impurities) luminescence emissions in crystals are briefly discussed. Merits and limitations of the available techniques are illustrated. CL emission changes as a function of the incident electron dose are illustrated for the case of natural quartz and sphalerite (ZnS) crystals. These effects are discussed in terms of the development of bulk charging, production of heat, diffusion of impurities, and creation of lattice defects induced by the incident ionizing particles. Although CL emission is mostly extrinsic in origin there is no general rule for identifying the nature of impurities from the CL emission spectra of minerals. However there is potential for using CL spectroscopy for trace element analysis as presented for the case of minerals containing rare-earth luminescent ions. The CL emission is a signature of the crystal-chemistry properties of minerals and hence contains potential genetic information. Some of the applications of CL emissions in the geosciences are summarized

Scanning Mechanical Microscopy of Laser Ablated Volumes Related to Inductively Coupled Plasma-Mass Spectrometry

Scanning mechanical microscopy based on the point by point sampling of the target surface was used to characterize volumes of minerals ablated by laser pulses (Nd: YAG, = 1064 nm, 140 μs pulse-width). Differentiated volumes resulting from vaporization and exfoliation mechanisms were selectively measured. Ablated volumes of natural pyrite (cubic FeS2), marcasite (orthorhombic FeS2) and arsenopyrite AsFeS, were transported into an inductively coupled plasma torch for subsequent mass analysis. The log of the S34 Fe57, and As75 mass intensities was linearly correlated with the log of the dimensions of the vaporized crater induced by the laser shots while large particles had no effect on the measured intensities. A memory effect for As was observed when a nylon tube was used to carry the ablated materials into the plasma torch. The memory effect was decreased by using a copper tube resulting probably from a difference in the electrical properties of the tubing systems leading to a lower adsorption of As within the copper tube than for the case of the nylon tube

Gestational breast cancer in New South Wales: A population-based linkage study of incidence, management, and outcomes.

BackgroundThe incidence of gestational breast cancer (GBC) is increasing in high-income countries. Our study aimed to examine the epidemiology, management and outcomes of women with GBC in New South Wales (NSW), Australia.MethodsA retrospective cohort study using linked data from three NSW datasets. The study group comprised women giving birth with a first-time diagnosis of GBC while the comparison group comprised women giving birth without any type of cancer. Outcome measures included incidence of GBC, maternal morbidities, obstetric management, neonatal mortality, and preterm birth.ResultsBetween 1994 and 2013, 122 women with GBC gave birth in NSW (crude incidence 6.8/ 100,000, 95%CI: 5.6-8.0). Women aged ≥35 years had higher odds of GBC (adjusted odds ratio (AOR) 6.09, 95%CI 4.02-9.2) than younger women. Women with GBC were more likely to give birth by labour induction or pre-labour CS compared to women with no cancer (AOR 4.8, 95%CI: 2.96-7.79). Among women who gave birth by labour induction or pre-labour CS, the preterm birth rate was higher for women with GBC than for women with no cancer (52% vs 7%; AOR 17.5, 95%CI: 11.3-27.3). However, among women with GBC, preterm birth rate did not differ significantly by timing of diagnosis or cancer stage. Babies born to women with GBC were more likely to be preterm (AOR 12.93, 95%CI 8.97-18.64), low birthweight (AOR 8.88, 95%CI 5.87-13.43) or admitted to higher care (AOR 3.99, 95%CI 2.76-5.76) than babies born to women with no cancer.ConclusionWomen aged ≥35 years are at increased risk of GBC. There is a high rate of preterm birth among women with GBC, which is not associated with timing of diagnosis or cancer stage. Most births followed induction of labour or pre-labour CS, with no major short term neonatal morbidity

A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice

Circulating tumor DNA (ctDNA) is a promising new biomarker with multiple potential applications in cancer care. Estimating total cost of ctDNA testing is necessary for reimbursement and implementation, but challenging because of variations in workflow. We aimed to develop a micro-costing framework for consistent cost calculation of ctDNA testing. First, the foundation of the framework was built, based on the complete step-wise diagnostic workflow of ctDNA testing. Second, the costing method was set up, including costs for personnel, materials, equipment, overhead, and failures. Third, the framework was evaluated by experts and applied to six case studies, including PCR-, mass spectrometry–, and next-generation sequencing–based platforms, from three Dutch hospitals. The developed ctDNA micro-costing framework includes the diagnostic workflow from blood sample collection to diagnostic test result. The framework was developed from a Dutch perspective and takes testing volume into account. An open access tool is provided to allow for laboratory-specific calculations to explore the total costs of ctDNA testing specific workflow parameters matching the setting of interest. It also allows to straightforwardly assess the impact of alternative prices or assumptions on the cost per sample by simply varying the input parameters. The case studies showed a wide range of costs, from €168 to €7638 ($199 to$9124) per sample, and generated information. These costs are sensitive to the (coverage of) platform, setting, and testing volume

Detection of desirable areas for urban growth through GIS and OWA: the case of Culiacan and Navolato

Debido al crecimiento acelerado de superficies artificiales, en las últimas dos décadas se ha observado un creciente interés en los cambios de uso de suelo, lo que hace necesario establecer modelos que generen planes de desarrollo óptimo y sustentable. De este modo, se busca identificar los espacios potencialmente más aptos para acoger el crecimiento urbano mediante simulaciones geoespaciales que integran a los Sistemas de Información Geográfica y OWA (Ordered Weighted Average). Para conseguirlo, se propone una metodología de análisis de sensibilidad a los resultados para comprobar su robustez a la variabilidad de los pesos de los factores de entrada, basada en clasificación por histogramas y distancias. Las propuestas de selección muestran un considerable porcentaje de acuerdo con al área programada

Prognostic value of microvessel density in stage II and III colon cancer patients:a retrospective cohort study

Background Microvessel density (MVD), as a derived marker for angiogenesis, has been associated with poor outcome in several types of cancer. This study aimed to evaluate the prognostic value of MVD in stage II and III colon cancer and its relation to tumour-stroma-percentage (TSP) and expression of HIF1A and VEGFA. Methods Formalin-fixed paraffin-embedded (FFPE) colon cancer tissues were collected from 53 stage II and 54 (5-fluorouracil-treated) stage III patients. MVD was scored by digital morphometric analysis of CD31-stained whole tumour sections. TSP was scored using haematoxylin-eosin stained slides. Protein expression of HIF1A and VEGFA was determined by immunohistochemical evaluation of tissue microarrays. Results Median MVD was higher in stage III compared to stage II colon cancers (11.1% versus 5.6% CD31-positive tissue area, p <0.001). High MVD in stage II patients tended to be associated with poor disease free survival (DFS) in univariate analysis (p = 0.056). In contrast, high MVD in 5FU-treated stage III patients was associated with better DFS (p = 0.006). Prognostic value for MVD was observed in multivariate analyses for both cancer stages. Conclusions MVD is an independent prognostic factor associated with poor DFS in stage II colon cancer patients, and with better DFS in stage III colon cancer patients treated with adjuvant chemotherapy